BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23228169)

  • 1. GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers.
    Hartmann S; Agostinelli C; Diener J; Döring C; Fanti S; Zinzani PL; Gallamini A; Bergmann L; Pileri S; Hansmann ML
    BMC Cancer; 2012 Dec; 12():586. PubMed ID: 23228169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
    Mikkilineni L; Whitaker-Menezes D; Domingo-Vidal M; Sprandio J; Avena P; Cotzia P; Dulau-Florea A; Gong J; Uppal G; Zhan T; Leiby B; Lin Z; Pro B; Sotgia F; Lisanti MP; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):218-225. PubMed ID: 29248133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography.
    Khandani AH; Dunphy CH; Meteesatien P; Dufault DL; Ivanovic M; Shea TC
    Nucl Med Commun; 2009 Aug; 30(8):594-601. PubMed ID: 19536037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
    Shim HK; Lee WW; Park SY; Kim H; Kim SE
    Oncol Res; 2009; 17(7):331-7. PubMed ID: 19408578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
    Chung JH; Cho KJ; Lee SS; Baek HJ; Park JH; Cheon GJ; Choi CW; Lim SM
    J Nucl Med; 2004 Jun; 45(6):999-1003. PubMed ID: 15181136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles.
    Nakagawa T; Yamada M; Suzuki Y
    J Nucl Med; 2008 Jul; 49(7):1053-9. PubMed ID: 18587087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.
    Sickinger MT; von Tresckow B; Kobe C; Engert A; Borchmann P; Skoetz N
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010533. PubMed ID: 25572491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.
    Afonso J; Pinto T; Simões-Sousa S; Schmitt F; Longatto-Filho A; Pinheiro C; Marques H; Baltazar F
    Cell Oncol (Dordr); 2019 Jun; 42(3):303-318. PubMed ID: 30790227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical Hodgkin lymphoma occurring in clusters of nodal marginal zone B-lymphocytes in association with progressive transformation of germinal center. A case report.
    Kojima M; Nakamura S; Shimizu K; Tanaka H; Yamane Y; Sugihara S; Masawa N
    Pathol Res Pract; 2003; 199(8):547-50. PubMed ID: 14533939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study.
    Barisik NO; Bozkurt S; Gumus M; Kaygusuz I; Karadayi N; Bas E; Bayik M; Tecimer T
    Diagn Pathol; 2010 Mar; 5():19. PubMed ID: 20346139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.
    Zwarthoed C; El-Galaly TC; Canepari M; Ouvrier MJ; Viotti J; Ettaiche M; Viviani S; Rigacci L; Trentin L; Rusconi C; Luminari S; Cantonetti M; Bolis S; Borra A; Darcourt J; Salvi F; Subocz E; Tajer J; Kulikowski W; Malkowski B; Zaucha JM; Gallamini A
    J Nucl Med; 2017 Aug; 58(8):1249-1254. PubMed ID: 28126883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma.
    Kiil K; Bein J; Schuhmacher B; Thurner L; Schneider M; Hansmann ML; Hartmann S
    Virchows Arch; 2018 Dec; 473(6):759-764. PubMed ID: 30259184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma.
    Steimle-Grauer SA; Tinguely M; Seada L; Fellbaum C; Hansmann ML
    Virchows Arch; 2003 Mar; 442(3):284-93. PubMed ID: 12647220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.
    Zhou X; Chen R; Xie W; Ni Y; Liu J; Huang G
    J Nucl Med; 2014 Nov; 55(11):1766-71. PubMed ID: 25342384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
    Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
    Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.
    Wein F; Otto T; Lambertz P; Fandrey J; Hansmann ML; Küppers R
    Haematologica; 2015 Oct; 100(10):1320-6. PubMed ID: 26160878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
    Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
    Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Trümper LH; von Bonin F; Kapp U; Patterson B; Snow BE; Mak TW
    Blood; 2001 Jan; 97(1):250-5. PubMed ID: 11133768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment.
    Touati M; Delage-Corre M; Monteil J; Abraham J; Moreau S; Remenieras L; Gourin MP; Dmytruk N; Olivrie A; Turlure P; Girault S; Labrousse F; Preux PM; Jaccard A; Bordessoule D
    Leuk Lymphoma; 2015 Feb; 56(2):332-41. PubMed ID: 24766492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: a report of two cases.
    Tatsuno M; Maeshima AM; Kim SW; Maruyama D; Taniguchi H; Miyamoto K; Fukuhara S; Kobayashi Y; Tobinai K; Kushima R
    Pathol Int; 2014 Dec; 64(12):613-7. PubMed ID: 25394195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.